Celerion

Phoenix, Arizona 85283

0 studies enrolling now · 14 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Decrease in Night Vision, Disturbance; Vision, Loss, Healthy, Healthy Participants Study, Healthy Subjects, Healthy Volunteer, Healthy Volunteers, Night Vision Complaints, Normal Volunteers, Refractory Chronic Cough

Studies at this site

• A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers — Completed
• First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants — Completed
• Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects — Completed
• Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers — Completed
• Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175 — Completed
• A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants — Completed
• The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances — Completed
• Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01 — Stopped early
• A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS) — Completed
• A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept® — Completed
• A First-in-Human Study of BNZ132-1-40 — Completed
• A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults — Completed
• A Single-Center, Open-Label, Randomized, 3-Treatment Crossover Bioavailability Study of Single Oral Doses of E5501 Old Tablet Formulation Under Fasted Conditions and a New Tablet Formulation Under Fed and Fasted Conditions in Healthy Subjects — Completed
• Formulation Comparison in Normal Volunteers — Completed